Member Info for clazas

worth a punt i'm in at 62.75 gl all hope it comes good had a good read and times report sounds promising

how long till news is it due in the next few weeks or longer

Irish win EU approval for deficit reduction By BFN News | 03:10 PM | Friday 15 April, 2011 The EU has given approval to the progress so far on deficit reduction in Ireland. As a condition of last year's bailout the country has to agree to EU monitoring and having looked at what has been achieved during the first three months of the year it is satisfied that the targets on deficit reduction have been met. The bailout agreed by Europe and the International Monetary Fund was worth £70bn. of whcih around 20% had to come from Ireland itself. Story provided by StockMarketWire.com

come on give us the good news we need to hear!

do really think we could hit 23cents next week meaning 21p on what basis I know it will eventually go up on news but whats due next week

why is sp on here saying 0.16 when it is really 13.7 sp and I just bought for 14.5 I see this moving up soon positive report, what was the old price by the way?

http://www.britishbulls.com/StockPage.asp?CompanyTicker=IPM&MarketTicker=Financials&TYP=S

can you put the rns on here please does this mean signs of recovery

this has massive potential and upside and has now been valued at 37p you work it out and dyor but i am staying put

should rise once profit takers go

saving nhs 400million a yr wow!

http://www.bbc.co.uk/news/health-12899316

Deltex Medical jump 50 percent as NICE recommends CardioQ for use in NHS 8:50 am by Jamie Ashcroft NICE estimates that CardioQ saves the NHS £1,100 per patient, per hospital stay. Deltex Medical’s (LON:DEMG) lead product, the CardioQ-ODM system, may now be used on 837,000 surgical NHS patients each year in England. CardioQ avoids invasive cardiovascular monitoring, it comprises a monitor and a single-patient disposable probe which is placed into the oesophagus through either the mouth or the nose with the tip of the probe positioned so that it is close to the descending aorta. The speed of blood travelling down the aorta is then measured by using a low-frequency ultrasound signal. This morning Deltex told investors the National Institute for Health and Clinical Excellence (NICE) - the NHS spending and efficiency watchdog - has extend its recommendation on the CardioQ. The news sparked a flurry of early trades that saw the stock soar over 50 percent. At 9:00 am Deltex shares were up 9.875 pence, 49.4 percent, changing hands at 29.875 pence each. NICE estimates that CardioQ saves the NHS £1,100 per patient, per hospital stay. It recommends that CardioQ should be used in "patients undergoing major or high-risk surgery or other surgical patients in whom a clinician would consider using invasive cardiovascular monitoring". Deltex chief executive Ewan Phillips said: "NICE's final guidance is a resounding endorsement for the CardioQ-ODM at a time when the NHS is charged with delivering £20 billion of efficiency savings over the next four years. “Implementing this guidance in full would be a significant step towards the NHS delivering these savings while improving considerably the care given to those patients undergoing major and high risk surgery.” In its recommendation NICE said there is a reduction in post-operative complications, use of central venous catheters and in-hospital stay when the CardioQ is used, compared with conventional clinical assessment with or without invasive cardiovascular monitoring

50%+

booooom time

think this will have nice rise today now

so this is going to 37p is it today :) imo

they owe me paying that much for them lol

thank u for that geseppe gl whens news due is it very soon?

neg buys only at mo but sp 3.27 I think going up defo tho